Similarly, the TRPV2 channel is overexpressed in ESCC cells and TRPV2 channel silencing suppresses ESCC cell proliferation and cell cycle progression, induces cell apoptosis, and is also associated with poor prognosis and low 5-year overall survival [58]. Here, TRPV2 is linked to esophageal squamous cell carcinoma.